Ringpu Bio-Technology completes investment partnership for pet sector

Tianjin Ringpu Bio-Technology Co., Ltd. announced the completion of the filing for its co-investment partnership, Tianjin Bairui Equity Investment Partnership (Limited Partnership), with the Asset Management Association of China. This follows board approval on October 13, 2025, to establish the partnership with entities including Tianjin Port Free Trade Zone Emerging Industry Development Fund Partnership (Limited Partnership) and Mingzhi Hexin (Tianjin) Equity Investment Fund Management Co., Ltd.

The partnership, with a total subscribed capital of 40,600 yuan, will focus on investments within the pet industry value chain. Ringpu Bio-Technology is contributing 15,400 yuan in capital as a limited partner, representing 37.9310% of the total subscribed capital. The partnership has been assigned the filing code SBJF29 and lists Mingzhi Hexin (Tianjin) Equity Investment Fund Management Co., Ltd. as the manager and Shanghai Pudong Development Bank Co., Ltd. as the custodian.

The filing was completed on November 3, 2025, in compliance with relevant laws and regulations such as the Securities Investment Fund Law and the Interim Measures for the Supervision and Administration of Private Investment Funds. The company pledged to continue fulfilling its information disclosure obligations regarding the partnership's future developments.